Australia does not need is a tax system that penalises patient saving, prudent risk-taking, and entrepreneurship.
TELIX Pharmaceuticals ( ASX: TLX) maintains its place at the top of the list as the ASX's most-shorted stock, with short ...
Geoff Wilson warns Australians under 40 could be hit with “double taxation”, crushing their money and home ownership dreams.
Mispricing is one thing. Capturing it is another. These REIT case studies show how active positioning can turn theory into ...
While value is one aspect of investing during periods of high inflation, it isn't the only story. Sometimes investors will ...
In a world of hype and headlines, systematic investing keeps investors grounded in what the data is really saying.
With markets rising, investors were often encouraged to add beta, concentrate exposures or take on higher levels of risk in ...
AI will reshape everything. That doesn’t mean today’s leaders will win. A global fund manager reveals where value is emerging ...
A near 40% drawdown has forced investors to reassess the healthcare sector. Is this a reset, or are deeper cracks starting to ...
A whiff of stagflation is back as rates hit 4.35%. Inflation is rising, growth is slowing - and the RBA may have no easy way ...
European equities have been playing second fiddle for years. Primarily because the US growth engine has been humming along ...
We’re fast entering a world where gold miners could be going the way of the dinosaurs. Rather than disappearing, they’re ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results